Skip to main content

Month: September 2023

Titan Announces Record Production and is on Track to Exceed 2023 Production Guidance; New Exploration Results Include 41ft at 37.6% Zinc

Mahler LocationMapMahlerDrillingVANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI) (“Titan” or the “Company”) is pleased to announce a new production record and that it is on track to exceed 2023 production guidance. In addition, new exploration results include 41ft at 37.6% zinc at its 100% owned Empire State Mines (“ESM”) located in upstate New York. HighlightsBest year to date safety performance with total recordable injury frequency at one-half of the national average A monthly production record of 7.2 million payable pounds of zinc in August 2023 (57% above the average monthly production from June 30, 2022 to June 30, 2023) 13.2 million payable pounds of zinc through the first two months of Q3 2023 (Q3 2023 tracking to exceed average quarterly production from...

Continue reading

InvestmentPitch Media Video Discusses Tres-Or Resources’ Acquiring the Exclusive Right to Develop Kimberlite Diamond Occurrences in the Coromandel Diamond District of Minas Gerais State, Brazil

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) — Tres-Or Resources (TSXV:TRS) (OTCPink:TRSFF), a Canadian diamond exploration company, has acquired the exclusive right to develop kimberlite diamond occurrences in the Coromandel diamond district of Minas Gerais State, Brazil. Through Tres-Or’s wholly owned Brazilian subsidiary, the company has entered into an exclusive development agreement that provides Tres-Or with the exclusive right to develop kimberlite diamond deposits on the Vendome Properties. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company, along with video comments from Laura Lee Duffett, President and CEO of Tres-Or...

Continue reading

Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD

Bionomics has collaborated with MSD to identify novel α7 nAChR PAMs suitable for the treatment of cognitive disorders like Alzheimer’s Disease Based on the learnings from Bionomics’ candidate BNC375, additional candidates have been developed with improved drug like and pharmacological properties that are currently in Phase 1 safety, tolerability, pharmacokinetics and biomarker studiesADELAIDE, Australia, and CAMBRIDGE, Mass., Sept. 14, 2023 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (“CNS”) disorders with high unmet medical need, today announced an update on the company’s α7 Nicotinic Acetylcholine Receptor (nAChR) Positive...

Continue reading

InvestmentPitch Media Video Discusses Foremost Lithium’s Completion of Summer Exploration Program on its “Lithium Lane Properties” near Snow Lake, Manitoba and Preparation for Drilling

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) — Foremost Lithium Resource & Technology Ltd. (NASDAQ:FMST) (CSE:FAT) (FSE:F0R), a North American hard-rock exploration company focusing on lithium, has completed an extensive summer exploration program on its “Lithium Lane Properties”, near the historic mining center of Snow Lake, Manitoba. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. If you are unable to view this video, please watch on InvestmentPitch Media’s YouTube channel at this link: (click here) Dahrouge Geological Consulting (“DGC”) completed a 19-day mapping and sampling program on the 43,000-acre four properties,...

Continue reading

Global Warming Solutions Inc. to Showcase Sustainable Energy Innovation at OCEANS 2023 Gulf Coast

Temecula, CA, Sept. 14, 2023 (GLOBE NEWSWIRE) — Global Warming Solutions Inc. (OTCQB: GWSO), a leader in renewable energy technology, announced today that it will be attending OCEANS 2023 Gulf Coast from September 25 to September 28 in Biloxi, Mississippi. As a premier partner event presented by the Marine Technology Society and IEEE Oceanic Engineering Society, OCEANS 2023 brings together over 500 technical presentations and more than 2000 exhibitors related to marine technology and ocean sustainability. GWSO and AQST experts will discuss how EcoHydroGen’s high-efficiency reactor is projected to outperform conventional electrolysis. Attendees can learn how this system:Provides silent auxiliary power for extended mobility and tool runtimes. Enables rapid deployment of resilient power after disasters. Allows self-sufficient...

Continue reading

Mangoceuticals Brand MangoRx Announced as Raindance Film Festival’s Headline Sponsor

The London-Based International Film Festival Will Feature the MangoRx Short Film Competition Focused on Mental Health and Erectile Dysfunction Dallas, Texas, Sept. 14, 2023 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” today announced it will be the headline sponsor for the thirty-first edition of the Raindance Film Festival, the UK’s leading indie film festival. Raindance returns to the heart of London’s West End from October 25 through November 4, 2023. As the headline sponsor of the 2023 festival, MangoRx will have a strong presence throughout the festival’s various programming...

Continue reading

Pulmonary Function Testing System Market Size to Surpass USD 214.1 Million by 2030, exhibiting a CAGR of 4.4%

As per the report by Fortune Business Insights, the global Pulmonary Function Testing System Market size is projected to reach USD 214.1 million in 2030, at a CAGR of 4.4% during the forecast period, 2023-2030Pulmonary Function Testing System MarketPulmonary Function Testing System Market (2023-2030)Pune, India, Sept. 14, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Pulmonary Function Testing System Market Size was valued at USD 152.3 million in 2022 and is projected to grow from USD 158.1 million in 2023 to USD 214.1 million by 2030, exhibiting a CAGR of 4.4% during the forecast period. Pulmonary Function Testing (PFT) system is a device that conducts a wide range of tests to detect a patient’s pulmonary functioning. These tests include nitrogen washout, respiratory mechanics, lung volumes,...

Continue reading

Prescription Drugs Market Size to Surpass USD 1864.2 Billion by 2030, exhibiting a CAGR of 8.9%

As per the report by Fortune Business Insights, The global prescription drugs market size was valued at USD 1,090.7 billion in 2022. The market is projected to grow from USD 1,162.6 billion in 2023 to USD 1,864.2 billion by 2030, exhibiting a CAGR of 8.9% during the forecast period.Prescription Drugs MarketForecast 2023-2030Pune, India, Sept. 14, 2023 (GLOBE NEWSWIRE) — Global prescription drugs market size was valued at USD 1,090.7 billion in 2022 The market is projected to grow from USD 1,864.2 billion by 2030, exhibiting a CAGR of 8.9% during forecast period. Prescription drugs are a wide range of vaccines and therapies used to treat and manage chronic and acute conditions. Common conditions include cancer, cardiovascular disease, diabetes, and rare diseases. In today’s clinical environment, proper prescription drugs...

Continue reading

mHealth Apps Market Size to Surpass USD 861.40 billion by 2030, exhibiting a CAGR of 40.2%

As per the report by Fortune Business Insights, the global mHealth Apps Market size is projected to reach USD 861.40 billion in 2030, at a CAGR of 40.2% during the forecast period, 2023-2030mHealth Apps MarketmHealth Apps Market Forecast 2023-2030Pune, India, Sept. 14, 2023 (GLOBE NEWSWIRE) — The mHealth apps market size was valued at USD 56.26 billion in 2022 and market is projected to reach USD 861.40 billion by 2030, recording a CAGR 40.2% during the forecast period. Technologies can help healthcare professionals make more efficient, accurate, and easier diagnoses. The factors are expected to boost mHealth apps market. Fortune Business Insights™ displays this information in a report titled, “mHealth Apps Market, 2023-2030.”Request a Free Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/mhealth-apps-market-102020Key...

Continue reading

Healthcare Architecture Market Size to Surpass USD 11.85 billion by 2030, exhibiting a CAGR of 4.8%

As per the report by Fortune Business Insights, the global Healthcare Architecture Market size is projected to reach USD 11.85 billion in 2030, at a CAGR of 4.8% during the forecast period, 2023-2030Healthcare Architecture MarketHealthcare Architecture Market Forecast (2023-2030)Pune, India, Sept. 14, 2023 (GLOBE NEWSWIRE) — Global healthcare architecture market size valued at USD 8.17 billion in 2022 and industry is expected to expand USD 11.85 billion by 2030, exhibiting a CAGR of 4.8% over forecast period. The expansion can be credited to growing healthcare infrastructure investment. Moreover, governments of emerging nations are investing huge amounts in healthcare sector. Fortune Business Insights™ provides this information in its research report, titled “Healthcare Architecture Market, 2023-2030”.Request...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.